EMSP News MS Research

Innovative Drug Delivery Treatment for Multiple Sclerosis

14.09.2018

The N2B-Patch is a project funded by the European Union, which brings together universities, research institutes, SMEs, industry and patients organisations to explore the possibility to have treatments (in MS) that bypass the Blood Brain Barrier (N2B-patch stands for Nose-to-Brain-patch).

Researchers aim to develop an innovative technology for multiple sclerosis (MS) treatment by developing a ‘nose to brain’ delivery system which will avoid the need for injections and oral medicine. The long-term objective is to improve treatment of MS patients.

The Nose to Brain Patch

 

Related Articles

EMSP Addresses MEP Interest Group on Critical MS Challenges in Europe

EMSP News News - EMSP

Reflecting on Progress: The EBV-MS Annual Consortium Meeting 2024

EMSP News MS Research

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .